key: cord-0711888-shfkl0bs authors: Kemp, SA; Collier, DA; Datir, R; Ferreira, IATM; Gayed, S; Jahun, A; Hosmillo, M; Rees-Spear, C; Mlcochova, P; Lumb, Ines Ushiro; Roberts, David J; Chandra, Anita; Temperton, N; Sharrocks, K; Blane, E; Briggs, JAG; van, Gils MJ; Smith, KGC; Bradley, JR; Smith, C; Doffinger, R; Ceron-Gutierrez, L; Barcenas-Morales, G; Pollock, DD; Goldstein, RA; Smielewska, A; Skittrall, JP; Gouliouris, T; Goodfellow, IG; Gkrania-Klotsas, E; Illingworth, CJR; McCoy, LE; Gupta, RK title: Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation date: 2020-12-29 journal: medRxiv DOI: 10.1101/2020.12.05.20241927 sha: 14c1b6dee3db4341bdb56f586aace72716ceabc5 doc_id: 711888 cord_uid: shfkl0bs SARS-CoV-2 Spike protein is critical for virus infection via engagement of ACE2, and amino acid variation in Spike is increasingly appreciated. Given both vaccines and therapeutics are designed around Wuhan-1 Spike, this raises the theoretical possibility of virus escape, particularly in immunocompromised individuals where prolonged viral replication occurs. Here we report chronic SARS-CoV-2 with reduced sensitivity to neutralising antibodies in an immune suppressed individual treated with convalescent plasma, generating whole genome ultradeep sequences by both short and long read technologies over 23 time points spanning 101 days. Although little change was observed in the overall viral population structure following two courses of remdesivir over the first 57 days, N501Y in Spike was transiently detected at day 55 and V157L in RdRp emerged. However, following convalescent plasma we observed large, dynamic virus population shifts, with the emergence of a dominant viral strain bearing D796H in S2 and ΔH69/ΔV70 in the S1 N-terminal domain NTD of the Spike protein. As passively transferred serum antibodies diminished, viruses with the escape genotype diminished in frequency, before returning during a final, unsuccessful course of convalescent plasma. In vitro, the Spike escape double mutant bearing ΔH69/ΔV70 and D796H conferred decreased sensitivity to convalescent plasma, whilst maintaining infectivity similar to wild type. D796H appeared to be the main contributor to decreased susceptibility, but incurred an infectivity defect. The ΔH69/ΔV70 single mutant had two-fold higher infectivity compared to wild type and appeared to compensate for the reduced infectivity of D796H. Consistent with the observed mutations being outside the RBD, monoclonal antibodies targeting the RBD were not impacted by either or both mutations, but a non RBD binding monoclonal antibody was less potent against ΔH69/ΔV70 and the double mutant. These data reveal strong selection on SARS-CoV-2 during convalescent plasma therapy associated with emergence of viral variants with reduced susceptibility to neutralising antibodies. 6 H 60 i n S 2 a n d ઢ o w e v e r , a m o n g s t R N A v i r u s e s c o r o n a v i r u s e s h a v e a r e l a t i v e l y m o d e s t 78 m u t a t i o n r a t e a t a r o u n d 2 3 n u c l e o t i d e s u b s t i t u t i o n s p e r y e a a r e o f p a r t i c u l a r c o n c e r n b e c a u s e t h e R B D i s a n i m p o r t a n t t a r g e t o f n e u t r a l i s i n g a n t i b o d i e s a n d 86 t h e r a p e u t i c m o n o c l o n a l a n t i b o d i e s . 87 D e l e t i o n s i n t h e N -t e r m i n a l d o m a i n ( N T D ) o f S p i k e S 1 h a v e a l s o b e e n i n c r e a s i n g l y r e c o g n i s e d , 89 b o t h w i t h i n h o s t s 9 a n d a c r o s s i n d i v i d u a l s 1 0 . T h e e v o l u t i o n a r y b a s i s f o r t h e e m e r g e n c e o f 90 d e l e t i o n s i s u n c l e a r a t p r e s e n t b u t c o u l d b e r e l a t e d t o e s c a p e f r o m i m m u n i t y o r t o e n h a n c e C l i n i c a l c a s e h i s t o r y o f S A R S -C o V -2 i n f e c t i o n i n s e t t i n g o f i m m u n e -c o m p r o m i s e d h o s t 106 C l i n i c a l d a t a a r e a v a i l a b l e f r o m t h e c o r r e s p o n d i n g a u t C o V -2 s p e c i f i c a n t i b o d i e s b y S p r o t e i n i m m u n o a s s a y ( S i e m e n s ) i n t h e h o s p i t a l d i a g n o s t i c 116 l a b o r a t o r y o n d a y s 6 8 , 9 0 a n d 1 0 1 . 117 118 V i r u s g e n o m i c c o m p a r a t i v e a n a l y s i s o f 2 3 s e q u e n t i a l r e s p i r a t o r y s a m p l e s o v e r 1 0 1 d a y s 119 T h e m a j o r i t y o f s a m p l e s w e r e r e s p i r a t o r y s a m p l e s f r o m n o s e a n d t h r o a t o r e n d o t r a c h e a l 120 a s p i r a t e s d u r i n g t h e p e r i o d o f i n t u b a t i o n . C t v a l u e s r a n g e d f r o m 1 6 -3 4 a n d a l l 2 3 r e s p i r a t o r s a m p l i n g s h o w e d e v i d e n c e o f v i r u s o n s u r f a c e s s u c h a s t e l e p h o n e a n d c a l l b e l l . S e q u e n c i n g o f 134 t h e s e s u r f a c e v i r u s e s s h o w e d c l u s t e r i n g w i t h t h o s e d e r i v e d f r o m t h e r e s p i r a t o r y t r a c t ( F i g u r e 135 2 B ) . A l l s a m p l e s w e r e c o n s i s t e n t w i t h h a v i n g a r i s e n f r o m a s i n g l e v i r a l p o p u l a t i o d i v e r s i f i c a t i o n a s t h e c a s e p a t i e n t . F u r t h e r i n v e s t i g a t i o n o f t h e s e q u e n c e d a t a s u g g e s t e d t h e 143 e x i s t e n c e o f a n u n d e r l y i n g s t r u c t u r e t o t h e v i r a l p o p u l a t i o n i n o u r p a t i e n t , w i t h s a m p l e s 144 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 29, 2020. ; D 7 9 6 H s i n g l e m u t a n t h a d s i g n i f i c a n t l y l o w e r i n f e c t i v i t y a s c o m p a r e d t o w i l d t y p e a n d t h e 231 d o u b l e m u t a n t h a d s i m i l a r i n f e c t i v i t y t o w i l d t y p e ( F i g u r e 6 B , s u p p l e m e n t a r y f i g u r e 7 ) . 232 233 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 29, 2020. ; https://doi.org/10.1101/2020.12.05.20241927 doi: medRxiv preprint ( F i g u r e 8 ) a n d a p p e a r s t o b e i n a r e g i o n f r e q u e n t l y t a r g e t e d b y a n t i b o d i e s 1 8 , d e s p i t e m u t a t i o n s 259 a t p o s i t i o n 7 9 6 b e i n g r a r e ( S u p p l e m e n t a r y t a b l e 7 ) . 260 T h e r e a r e c l e a r l y a 295 CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 29, 2020. ; https://doi.org/10.1101/2020.12.05.20241927 doi: medRxiv preprint t h a t i t s h o u l d b e r e s e r v e d f o r u s e w i t h i n c l i n i c a l t r i a l s , w i t h r i g o r o u s m o n i t o r i n g o f c l i n i c a l a n d 345 v i r o l o g i c a l p a r a m e t e r s . T h e d a t a f r o m t h i s s i n g l e c a s e r e p o r t m i g h t w a r r a n t c a u t i o n i n u s e o f 346 c o n v a l e s c e n t p l a s m a i n p a t i e n t s w i t h i m m u n e s u p p r e s s i o n o f b o t h T c e l l a n d B c e l l a r m s ; i n s u c . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 29, 2020. ; https://doi.org/10.1101/2020.12.05.20241927 doi: medRxiv preprint 2 3 B o s h i e r , F . A . T . e t a l . R e m d e s i v i r i n d u c e d v i r a l R N A a n d s u b g e n o m i c R N A s u p p r e s s i o n , a n d 653 e v o l u t i o n o f v i r a l v a r i a n t s i n S A R S -C o V -2 i n f e c t e d p a t i e n t . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 29, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 29, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 There were few nucleotide substitutions between days 1-54, despite the patient receiving two courses of remdesivir. The first major changes in the spike genome occurred on day 82, following convalescent plasma given on days 63 and 65. The amino acid deletion in S1, ΔH69/V70 is indicated by the black lines. Sites: Endotracheal aspirate (ETA) or Nose/throat swabs (N+T). At baseline, all four S variants (Illumina sequencing) were absent (<1% and <20 reads). Approximately two weeks after receiving two units of convalescent plasma (CP), viral populations carrying ΔH69/V70 and D796H mutants rose to frequencies >90% but decreased significantly four days later. This population was replaced by a population bearing Y200H and T240I, detected in two samples over a period of 6 days. These viral populations were then replaced by virus carrying W64G and P330S mutations in Spike, which both dominated at day 93. Following a 3 rd course of remdesivir and an additional unit of convalescent plasma, the ΔH69/V70 and D796H virus population re-emerged to become the dominant viral strain reaching variant frequencies of >90%. Pairs of mutations arose and disappeared simultaneously indicating linkage on the same viral haplotype. CT values from respiratory samples are indicated on the right y-axis (black triangles) B. Maximum likelihood phylogenetic tree of the case patient with day of sampling indicated. Spike mutations defining each of the clades are shown ancestrally on the branches on which they arose. On dates where multiple samples were collect, these are indicated as endotracheal aspirate (ETA) and Nose + throat swabs (N+T). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perp (which was not certified by peer review) preprint The copyright holder for th this version posted December 29, 2020. ; https://doi.org/10.1101/2020.12.05.20241927 doi: medRxiv preprint Figure 6 : Spike mutant D796H + ΔH69/V70 has infectivity comparable to wild type but is less sensitive to multiple units of convalescent plasma (CP). A. western blot of virus pellets after centrifugation of supernatants from cells transfected with lentiviral pseudotyping plasmids including Spike protein B. Single round Infectivity of luciferase expressing lentivirus pseudotyped with SARS-CoV-2 Spike protein (WT versus mutant) on 293T cells co-transfected with ACE2 and TMPRSS2 plasmids. Infectivity is corrected for reverse transcriptase activity in virus supernatant as measured by real time PCR C-E. convalescent plasma (CP units 1-3) neutralization potency. against pseudovirus virus bearing Spike mutants D796H, ΔH69/V70 and D796H + ΔH69/V70 F, G patient serum neutralisation potency against pseudovirus virus bearing Spike mutants D796H, ΔH69/V70 and D796H + ΔH69/V70. Patient serum was taken at indicated Day (D). Indicated is serum dilution required to inhibit 50% of virus infection (ID50). Data points represent means of technical replicates and each data point is an independent exp. is the author/funder, who has granted medRxiv a license to display the preprint in perp (which was not certified by peer review) preprint The copyright holder for th this version posted December 29, 2020. ; https://doi.org/10.1101/2020.12.05.20241927 doi: medRxiv preprint Figure 8 . Location of Spike mutations ΔH69/Y70 in S1 and D796H in S2. Amino acid residues H69 and Y70 deleted in the N-terminal domain (red) and D796H in subunit 2 (orange) are highlighted on a SARS-CoV-2 spike trimer (PDB: 6ZGE Wrobek et al., 2020). Each of the three protomers making up the Spike homotrimer are coloured separately in shades of grey (centre). Close-ups of ΔH69/Y70 (above) and D796H (below) are shown in cartoon, stick representation. Both mutations are in exposed loops. Figure 7 ). Clusters II, V contain only non-neutralising mAbs, smaller neutralising mAb clusters IV (n=2) and X (n=1) were not tested. Red indicates significant fold changes. To ensure that the patient case was not resultant of a superinfection event, all patient sequences were aligned with a snapshot of global SARS-CoV-2 sequences downloaded from the GISAID database between 1 st April and 5 th May (26472 sequences, only full sequences and excluding all low coverage sequences). Sequences were aligned using MAFFT and a maximum-likelihood tree inferred with IQTREE v2.1.3. All 23 sequenced from the patient case (red) formed a distinct clade, suggesting that all viral populations diversified within-host. Illumina Nanopore Illumina Nanopore Illumina Nanopore Illumina Nanopore Illumina Nanopore Illumina Nanopore Illumina Nanopore I n -d e p t h a l l e l e f r e q u e n c y v a r i a n t c a l l i n g 491 T h e S A M F I R E p a c k a g e 3 9 w a s u s e d t o c a l l a l l e l e f r e q u e n c y t r a j e c t o r i e s f r o m B A M f i l e d a t a . R e a d s 492 w e r e i n c l u d e d i n t h i s a n a l y s i s i f t h e y h a d a m e d i a n P H R E D s c o r e o f a t l e a s t 3 0 , t r i m m i n g t Table 1 : Immunological parameters of patient pre-and post-receipt of convalescent plasma (CP) demonstrating profound lymphopenia with reduction in total serum IgG and IgA. The patient continued to have normal serum IgM which either reflects his underlying lymphoproliferative state or ongoing infection. Following receipt of CP the presence of SARS-CoV-2 antibodies is evident. Figure 2B . Pangolin lineages were identified using Pangolin COVID-19 Lineage Assigner v2.0.8 (https://pangolin.cog-uk.io/).. CP-convalescent plasma; mAb -monoclonal antibody. The patient initially presented with ground glass and peribroncho-vascular consolidation with associated intralobular septal thickening/reticulation and architectural distortion and interlobular septal thickening. By day 50 there is some improvement with evidence of resolving pnuemonitis, however, his condition deteriorated following the detection of bilateral pulmonary emboli, a well-recognized complication of SARS-CoV-2. Despite multiple therapeutic interventions, the patient's condition deteriorated with worsening of inflammatory changes and chronic organizing pneumonia (COP), particularly on the left, and ongoing changes compatible with persistent SARS-CoV2 infection. Points are the frequency of the variant at each timepoint; only 20 samples were sequenced using the Illumina method. Boxes represent inter-quartile ranges. Error bars are 95% CI. There was good concordance for mutations between the two methods, and no significant difference between the proportion of reads measured by both methods.